High-grade Pleomorphic Sarcoma Associated with Metallosis in a Patient with Total Hip Arthroplasty

Abstract

Although the relationship between hip arthroplasty and the development of sarcoma was first described in the literature about forty years ago, this association is extremely rare. In the present case report, we describe the association between orthopedic implants and soft tissue sarcoma in a 79-year-old man who underwent primary total hip arthroplasty (THA) for coxarthrosis 24 years ago. In the present case report, we describe the clinical evolution and the radiographic and histopathological findings of the lesion. In the intraoperative period of the second revision surgery, loosening of the acetabular and femoral components in association with extensive areas of necrosis and metallosis was evidenced. We performed debridement of the hip and right thigh region and removed the implants. Due to the extent of the lesion and to necrosis, it was not possible to perform a new joint reconstruction. The histopathological diagnosis of high-grade undifferentiated pleomorphic sarcoma associated with extensive areas of metallosis was confirmed in tissue adjacent to the implant. The patient developed pulmonary metastases and died 6 months after the diagnosis. Despite the rarity of this association, sarcomas should be considered in the differential diagnosis of aseptic loosening, especially in the presence of metallosis in the peri-implant tissue. To our knowledge, the 24-year latency period between primary THA and the establishment of a sarcoma diagnosis is one of the longest reported to date.

Keywords

arthroplasty, replacement, hip - hip prosthesis - metals - sarcoma

Study carried out at the Instituto Nacional de Traumatologia e Ortopedia (National Institute of Traumatology and Orthopedics), Rio de Janeiro, RJ, Brazil.

Publication History

Received: 10 December 2020

Accepted: 02 June 2021

Article published online:
13 October 2021

• Referências

• 1 Purdue PE, Koulouvaris P, Potter HG, Nestor BJ, Sculco TP. The cellular and molecular biology of periprosthetic osteolysis. Clin Orthop Relat Res 2007; 454 (454) 251-261
• 2 Bagó-Granell J, Aguirre-Canyadell M, Nardi J, Tallada N. Malignant fibrous histiocytoma of bone at the site of a total hip arthroplasty. A case report. J Bone Joint Surg Br 1984; 66 (01) 38-40
• 3 Visuri T, Pulkkinen P, Paavolainen P. Malignant tumors at the site of total hip prosthesis. Analytic review of 46 cases. J Arthroplasty 2006; 21 (03) 311-323
• 4 Stiller CA, Botta L, Brewster DH. et al; EUROCARE-5 Working Group. Survival of adults with cancers of bone or soft tissue in Europe-Report from the EUROCARE-5 study. Cancer Epidemiol 2018; 56: 146-153
• 5 Lamovec J, Zidar A, Cucek-Plenicar M. Synovial sarcoma associated with total hip replacement. A case report. J Bone Joint Surg Am 1988; 70 (10) 1558-1560
• 6 Kavalar R, Fokter SK, Lamovec J. Total hip arthroplasty-related osteogenic osteosarcoma: case report and review of the literature. Eur J Med Res 2016; 21: 8-13
• 7 Terrando S, Sambri A, Bianchi G. et al. Angiosarcoma around total hip arthroplasty: case series and review of the literature. Musculoskelet Surg 2018; 102 (01) 21-27
• 8 Ekman E, Laaksonen I, Eskelinen A, Pulkkinen P, Pukkala E, Mäkelä K. Midterm risk of cancer with metal-on-metal hip replacements not increased in a Finnish population. Acta Orthop 2018; 89 (05) 575-579
• 9 Raghunathan VK, Devey M, Hawkins S. et al. Influence of particle size and reactive oxygen species on cobalt chrome nanoparticle-mediated genotoxicity. Biomaterials 2013; 34 (14) 3559-3570
• 10 Sarhadi VK, Parkkinen J, Reito A. et al. Genetic alterations in periprosthetic soft-tissue masses from patients with metal-on-metal hip replacement. Mutat Res 2015; 781: 1-6